Penumbra Inc. is a global healthcare company that specializes in innovative medical devices and therapies. The company was founded in 2004 and is headquartered in Alameda, California. Penumbra is publicly traded on the New York Stock Exchange under the ticker symbol "PEN."
Penumbra is known for its flagship product, the Penumbra System, which is used for neurovascular and peripheral vascular diseases. The Penumbra System is a minimally invasive device that enables physicians to remove blood clots or restore blood flow in patients suffering from conditions such as stroke, aneurysms, and deep vein thrombosis. The system consists of a variety of catheters, guidewires, aspiration pumps, and other tools.
The company's history is closely tied to the development and commercialization of the Penumbra System. Since its founding, Penumbra has focused on advancing the treatment of challenging medical conditions through innovative and clinically effective solutions. The Penumbra System has gained recognition and has been widely adopted by healthcare professionals around the world.
In addition to the Penumbra System, the company offers a range of other products designed to address specific medical needs. These include the Penumbra Coil 400 for the treatment of cerebral aneurysms and the Indigo System for peripheral vascular thrombectomy. Penumbra continues to invest in research and development to expand its product portfolio and improve patient outcomes.
Penumbra's commitment to innovation and patient care has been recognized through various awards and accolades. The company has received multiple FDA clearances and approvals for its products, demonstrating their safety and effectiveness. Penumbra's dedication to continuous improvement and clinical advancements has positioned it as a trusted leader in the medical device industry.